✦ LIBER ✦

PCN34 COST-EFFECTIVENESS OF GEFITINIB FOR FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER: A MARKOV MODEL-BASED ANALYSIS

✍ Scribed by PH Liu; FC Hu; JD Wang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

P-320 Gefitinib therapy of advanced non

✍ Chouaid, C.; Monnet, I.; Robinet, G.; Perol, M.; Fournel, P.; Vergnenegre, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 296 KB

PCN23 A COST MINIMIZATION ANALYSIS OF FI

✍ K Le Lay; L Riou-França; S Avoinet; N Chemali; A Vergnenègre; R Launois 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCN109 Cost Effectiveness of First Line

✍ Borget, I.; Vergnenegre, A.; Chouaid, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

OP3 Cost-effectiveness of epidermal grow

✍ G. de Lima Lopes; J. Segel; D. Tan; Y. Do; T. Mok; E. Finkelstein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

PCN90 Cost-Effectiveness Analysis of Erl

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB